InMed Pharmaceuticals Inc. (NASDAQ: INM) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT INMED PHARMACEUTICALS INC.

InMed Pharmaceuticals Inc. (NASDAQ: INM)
Listen to this Section


$1.48
-0.0300 ( -1.99% ) 20.3K

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Market Data


Open $1.48
Previous Close $1.51
Volume 20.3K
Market Cap $5.00M
Day Range $1.48 - $1.51
52 Week Range $0.58 - $5.50
Shares Outstanding 3.31M
Change % -1.99%
Net Change ▼ -0.0300
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2020
CountryCanada
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -314,750.00

Date Type Amount Purchased Purchaser
2024-08-02 Sale -240.00 MANCINI ALEXANDRA DIANE JANET
2024-05-28 Sale -1139.00 ADAMS ERIC A
2024-05-28 Sale -545.00 HSU ERIC C
2024-05-28 Sale -485.00 MANCINI ALEXANDRA DIANE JANET
2024-05-28 Sale -394.00 WOUDENBERG MICHAEL
2024-03-05 Sale -121.00 MANCINI ALEXANDRA DIANE JANET
2024-03-05 Sale -309.00 HSU ERIC C
2024-03-05 Sale -42.00 HULL ANDREW
2024-02-22 Buy 37500.00 HULL ANDREW
2024-02-21 Buy 41600.00 ADAMS ERIC A

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Sep 23, 2025
8-k 8K-related 14 Sep 23, 2025
10-k Annual reports 93 Sep 23, 2025
8-k 8K-related 15 Sep 08, 2025
8-k 8K-related 14 Jul 28, 2025
8-k 8K-related 22 Jun 30, 2025
8-k 8K-related 15 Jun 24, 2025
8-k 8K-related 14 Jun 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy